Publication:

Preoperative asymptomatic leukocytosis and postoperative outcome in cardiac surgery patients

Loading...
Thumbnail Image

Open/View Files

Date

2017

Journal Title

Journal ISSN

Volume Title

Publisher

Public Library of Science
The Harvard community has made this article openly available. Please share how this access benefits you.

Research Projects

Organizational Units

Journal Issue

Citation

Mahmood, Eitezaz, Ziyad O. Knio, Feroze Mahmood, Rabia Amir, Sajid Shahul, Bilal Mahmood, Yanick Baribeau, Ariel Mueller, and Robina Matyal. 2017. “Preoperative asymptomatic leukocytosis and postoperative outcome in cardiac surgery patients.” PLoS ONE 12 (9): e0182118. doi:10.1371/journal.pone.0182118. http://dx.doi.org/10.1371/journal.pone.0182118.

Abstract

Background: Despite showing a prognostic value in general surgical patients, preoperative asymptomatic elevated white blood cell (WBC) count is not considered a risk factor for cardiac surgery. Whereas there is sporadic evidence of its value as a preoperative risk marker, it has not been looked at methodically as a specific index of outcome during cardiac surgery. Using a national database we sought to determine the relationship between preoperative WBC count and postoperative outcome in cardiac surgical patients. Methods: Cardiac surgeries were extracted from the 2007–2013 American College of Surgeons National Surgical Quality Improvement Program database. Leukocytosis was defined by a preoperative WBC count greater than 11,000 cells/μL. A univariate analysis compared the incidence of adverse outcomes for patients with and without leukocytosis. A multivariate logistic regression model was constructed in order to test whether leukocytosis was an independent predictor of morbidity and mortality. Results: Out of a total of 10,979 cardiac surgery patients 863 (7.8%) had preoperative leukocytosis. On univariate analysis, patients with leukocytosis experienced greater incidences of 30-day mortality, wound complications, and medical complications. Wound complications included surgical site infection as well as wound dehiscence. The medical complications included all other non-surgical causes of increased morbidity and infection leading to urinary tract infection, pneumonia, ventilator dependence, sepsis and septic shock. After stepwise model adjustment, leukocytosis was a strong predictor of medical complications (OR 1.22, 95% CI: 1.09–1.36, p = 0.002) with c-statistic of 0.667. However, after stepwise model adjustment leukocytosis was not a significant predictor of 30-day mortality and wound complications. Conclusion: Preoperative leukocytosis is associated with adverse postoperative outcome after cardiac surgery and is an independent predictor of infection-related postoperative complications.

Description

Research Data

Keywords

Medicine and Health Sciences, Oncology, Cancers and Neoplasms, Hematologic Cancers and Related Disorders, Myeloproliferative Disorders, Leukocytosis, Hematology, Surgical and Invasive Medical Procedures, Cardiovascular Procedures, Cardiac Surgery, Cardiology, Myocardial Infarction, Pulmonology, Chronic Obstructive Pulmonary Disease, Diagnostic Medicine, Signs and Symptoms, Sepsis, Systemic Inflammatory Response Syndrome, Pathology and Laboratory Medicine

Terms of Use

This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service

Endorsement

Review

Supplemented By

Related Stories